275 related articles for article (PubMed ID: 15452671)
1. Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure.
Nakata T; Wakabayashi T; Kyuma M; Takahashi T; Tsuchihashi K; Shimamoto K
Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):186-94. PubMed ID: 15452671
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
Kasama S; Toyama T; Sumino H; Nakazawa M; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
J Nucl Med; 2008 Jun; 49(6):907-14. PubMed ID: 18483106
[TBL] [Abstract][Full Text] [Related]
3. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
[TBL] [Abstract][Full Text] [Related]
4. Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
J Nucl Med; 2003 Jun; 44(6):884-90. PubMed ID: 12791814
[TBL] [Abstract][Full Text] [Related]
5. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function.
Nagahara D; Nakata T; Hashimoto A; Wakabayashi T; Kyuma M; Noda R; Shimoshige S; Uno K; Tsuchihashi K; Shimamoto K
J Nucl Med; 2008 Feb; 49(2):225-33. PubMed ID: 18199625
[TBL] [Abstract][Full Text] [Related]
6. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure.
Takeishi Y; Atsumi H; Fujiwara S; Takahashi K; Tomoike H
J Nucl Med; 1997 Jul; 38(7):1085-9. PubMed ID: 9225795
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin II receptor antagonists on [(123)I]metaiodobenzylguanidine myocardial imaging findings and neurohumoral factors in chronic heart failure.
Shinohara H; Fukuda N; Soeki T; Sakabe K; Onose Y; Tamura Y
Heart Vessels; 2002 Dec; 17(2):47-52. PubMed ID: 12541093
[TBL] [Abstract][Full Text] [Related]
8. Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ishikawa T; Ichikawa S; Suzuki T; Kurabayashi M
J Nucl Med; 2004 Jul; 45(7):1108-13. PubMed ID: 15235055
[TBL] [Abstract][Full Text] [Related]
9. Cardiac 123 I-MIBG imaging and clinical variables in risk stratification in patients with heart failure treated with beta blockers.
de Milliano PA; Tijssen JG; van Eck-Smit BL; Lie KI
Nucl Med Commun; 2002 Jun; 23(6):513-9. PubMed ID: 12029205
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine.
Gerson MC; Craft LL; McGuire N; Suresh DP; Abraham WT; Wagoner LE
J Nucl Cardiol; 2002; 9(6):608-15. PubMed ID: 12466785
[TBL] [Abstract][Full Text] [Related]
11. Synergistic prognostic implications of left ventricular mechanical dyssynchrony and impaired cardiac sympathetic nerve activity in heart failure patients with reduced left ventricular ejection fraction.
Doi T; Nakata T; Yuda S; Hashimoto A
Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):74-83. PubMed ID: 28158459
[TBL] [Abstract][Full Text] [Related]
12. Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure.
Kyuma M; Nakata T; Hashimoto A; Nagao K; Sasao H; Takahashi T; Tsuchihashi K; Shimamoto K
J Nucl Med; 2004 Feb; 45(2):155-63. PubMed ID: 14960630
[TBL] [Abstract][Full Text] [Related]
13. Predicting Risk Versus Predicting Potential Survival Benefit Using 123I-mIBG Imaging in Patients With Systolic Dysfunction Eligible for Implantable Cardiac Defibrillator Implantation: Analysis of Data From the Prospective ADMIRE-HF Study.
Hachamovitch R; Nutter B; Menon V; Cerqueira MD
Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26666380
[TBL] [Abstract][Full Text] [Related]
14. Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy.
Toyama T; Aihara Y; Iwasaki T; Hasegawa A; Suzuki T; Nagai R; Endo K; Hoshizaki H; Oshima S; Taniguchi K
J Nucl Med; 1999 Feb; 40(2):217-23. PubMed ID: 10025826
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of the angiotensin-converting enzyme inhibitor enalapril on chronic heart failure. Examination by 123I-MIBG imaging.
Soeki T; Tamura Y; Bandou K; Tanaka H; Takeichi N; Shinohara H; Yui Y; Fukuda N; Sui O
Jpn Heart J; 1998 Nov; 39(6):743-51. PubMed ID: 10089936
[TBL] [Abstract][Full Text] [Related]
16. Persistence of
Piña IL; Carson P; Lindenfeld J; Archambault WT; Jacobson AF
Am J Cardiol; 2017 Feb; 119(3):434-439. PubMed ID: 27912890
[No Abstract] [Full Text] [Related]
17. Creation of mortality risk charts using 123I meta-iodobenzylguanidine heart-to-mediastinum ratio in patients with heart failure: 2- and 5-year risk models.
Nakajima K; Nakata T; Matsuo S; Jacobson AF
Eur Heart J Cardiovasc Imaging; 2016 Oct; 17(10):1138-45. PubMed ID: 26705487
[TBL] [Abstract][Full Text] [Related]
18. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of meta-[123I]iodobenzylguanidine myocardial scintigraphy for predicting cardiac events in patients with dilated cardiomyopathy who receive long-term beta blocker treatment.
Fujimoto S; Inoue A; Hisatake S; Yamashina S; Yamashina H; Nakano H; Yamazaki J
Nucl Med Commun; 2005 Feb; 26(2):97-102. PubMed ID: 15657500
[TBL] [Abstract][Full Text] [Related]
20. Cardiac 123I-MIBG Imaging for Clinical Decision Making: 22-Year Experience in Japan.
Nakajima K; Nakata T
J Nucl Med; 2015 Jun; 56 Suppl 4():11S-19S. PubMed ID: 26033897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
